Stereotactic radiotherapy for oligometastatic cancer: A prognostic model for survival

Annals of Oncology

Volumn 25, Issue 2, 2014, Pages 467-471

  de Vin, T ^a   Engels, B ^a   Gevaert, T ^a   Storme, G ^a   De Ridder, M ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Oligometastases; Prognostic model; Risk factors; Stereotactic body radiotherapy; Stereotactic radiosurgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRACRANIAL METASTASIS; FEMALE; HUMAN; INTRACRANIAL METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; OLIGOMETASTATIC CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STEREOTACTIC RADIOTHERAPY; STEREOTACTIC TREATMENT; SURVIVAL RATE; SURVIVAL TIME; SYNCHRONOUS OLIGOMETASTATIC DISEASE; VERY ELDERLY; ADENOCARCINOMA; BRAIN NEOPLASMS; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIOSURGERY; SECONDARY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84893379567     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt537     Document Type: Article

References (31)

1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995; 13: 8-10.
2. Weichselbaum RR, Ishwaran H, Yoon T et al. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA 2008; 105: 18490-18495.
3. Gupta GP, Messagué J. Cancer metastasis: building a framework. Cell 2006; 127: 679-695.
4. Stephens PJ, Greenman CD, Fu B et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011; 144: 27-40.
5. Korbel JO, Campbell PJ. Criteria for inference of chromothripsis in cancer genomes. Cell 2013; 152: 1126-1136.
6. Fong Y, Blumgart LH, Cohen AM. Surgical treatment of colorectal metastases to the liver. CA Cancer J Clin 1995; 45: 50-62.
7. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77: 1241-1246.
8. Timmerman RD, Bizekis CS, Pass HI et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59: 145-170.
9. Badakhshi H, Grün A, Stromberger C et al. Oligometastases: the new paradigm and options for radiotherapy. A critical review. Strahlenther Onkol 2013; 189: 357-362.
10. Alongi F, Arcangeli S, Filippi AR et al. Review and uses of stereotactic body radiation therapy for oligometastases. Oncologist 2012; 17: 1100-1107.
11. Engels B, Everaert H, Gevaert T et al. Phase II study of helical tomotherapy for oligometastatic colorectal cancer. Ann Oncol 2011; 22: 362-368.
12. Engels B, Gevaert T, Everaert H et al. Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer. Radiat Oncol 2012; 7: 34.
13. Corbin KS, Hellman S, Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol 2013; 31: 1384-1390.
14. Milano MT, Katz AW, Muhs AG et al. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008; 112: 650-658.
15. Rusthoven KE, Kavanagh BD, Cardenes H et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009; 27: 1572-1578.
16. Chu JE, Allan AL. The role of cancer stem cells in the organ tropism of breast cancer metastasis: a mechanistic balance between the 'Seed' and the 'Soil'? Int J Breast Cancer 2012 [epub ahead of print], doi:10.1155/2012/209748.
17. Boucher Y, Salehi H, Witwer B et al. Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 1997; 75: 829-836.
18. Sanghavi SN, Miranpuri SS, Chapell R et al. Radiosurgery for patients with brain metastasis: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. Int J Radiat Oncol Biol Phys 2001; 51: 426-434.
19. Gupta T. Stereotactic radiosurgery for brain oligometastases: good for some, better for all?. Ann Oncol 2005; 16: 1749-1754.
20. Fong Y, Fortner J, Sun RL et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318.
21. Pastorino U, Buyse M, Friedel G et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113: 37-49.
22. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol 2011; 8: 378-382.
23. Niibe Y, Chang JY. Novel insights of oligometastases and oligo-recurrence and review of the literature. Pulm Med 2012; 2012: 261096.
24. De Ruysscher D, Wanders R, van Baardwijk A et al. Radical treatment of nonsmall- cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 2012; 7: 1547-1555.
25. Bohanes P, Yang D, Chhibar RS et al. Influence of sex on the survival of patients with esophageal cancer. J Clin Oncol 2012; 30: 2265-2272.
26. Hendifar A, Yang D, Lenz F et al. Gender disparities in metastatic colorectal cancer survival. Clin Cancer Res 2009; 15: 6391-6397.
27. Mervic L. Time course and pattern of metastasis of cutaneous melanoma differ between men and women. PLoS One 2012; 7: e32955.
28. Tree AC, Khoo VS, Eeles RA et al. Stereotactic body radiotherapy for oligometastases. Lancet Oncol 2013; 14: e28-e37.
29. Bignardi M, Navarria P, Mancosu P et al. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 2011; 81: 831-838.
30. Salama JK, Hasselle MD, Chmura SJ et al. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2011; 118: 2962-2970.
31. Kao J, Chen CT, Tong CC et al. Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases. Target Oncol 2013. May 2013 [epub ahead of print] doi:10.1007/s11523-013-0280-y.